Cancer drug measurement and metabolism specialist
Cancer Pharmacokinetics Research Specialist
Supports a specialist who develops advanced tests to measure how cancer drugs move through and are broken down in the body for people with cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11175293 on NIH RePORTER |
What this research studies
This award funds a Cancer Pharmacokinetics Research Specialist at the UPMC Hillman Cancer Center who develops and validates laboratory methods (like LC‑MS/MS) to measure drug levels and metabolites. The specialist upgrades and learns to use new instruments and software, and trains other staff so the facility can run more and better tests. Their work applies to both laboratory (preclinical) studies and clinical samples taken from patients in cancer trials. The goal is to provide reliable drug‑level data that supports early drug development and safer dosing.
Who could benefit from this research
Good fit: Patients enrolled in cancer clinical trials or receiving systemic cancer drugs who can provide blood or tissue samples for drug‑level and metabolism testing would be most relevant.
Not a fit: Patients not receiving systemic cancer therapy or not enrolled in trials that collect pharmacokinetic samples would likely see no direct benefit from this award.
Why it matters
Potential benefit: If successful, this work could help doctors choose safer, more effective drug doses by giving precise information about drug levels and metabolism in cancer patients.
How similar studies have performed: Using LC‑MS/MS and related methods to measure drug levels is an established and widely used approach in cancer drug development.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Parise, Robert — University of Pittsburgh at Pittsburgh
- Study coordinator: Parise, Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.